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Abstract
Craniofacial defects that occur through gene mutation during development increase vulnerability to eustachian tube
dysfunction. These defects can lead to an increased incidence of otitis media. We examined the effects of a mutation in the
Sh3pxd2b gene (Sh3pxd2b
nee) on the progression of otitis media and hearing impairment at various developmental stages.
We found that all mice that had the Sh3pxd2b
nee mutation went on to develop craniofacial dysmorphologies and
subsequently otitis media, by as early as 11 days of age. We found noteworthy changes in cilia and goblet cells of the
middle ear mucosa in Sh3pxd2b
nee mutant mice using scanning electronic microscopy. By measuring craniofacial
dimensions, we determined for the first time in an animal model that this mouse has altered eustachian tube morphology
consistent with a more horizontal position of the eustachian tube. All mutants were found to have hearing impairment.
Expression of TNF-a and TLR2, which correlates with inflammation in otitis media, was up-regulated in the ears of mutant
mice when examined by immunohistochemistry and semi-quantitative RT-PCR. The mouse model with a mutation in the
Sh3pxd2b gene (Sh3pxd2b
nee) mirrors craniofacial dysmorphology and otitis media in humans.
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Introduction
Otitis media (OM) is a prevalent problem in children under the
age of 15 [1,2]. OM can be acute or chronic and can be
accompanied by excessive middle ear effusion, an accumulation of
fluid in the middle ear [1,2,3]. By the age of 10, about 80% of
children have had at least one case of OM with effusion [3,4,5,6],
caused by eustachian tube dysfunction. This is the leading cause of
impaired hearing in children [7]. The eustachian tube is the only
ventilation pathway of the middle ear cavity, interconnecting the
nasopharynx and the external environment. Thus, it is crucial in
clearing the middle ear of excessive effusion and in balancing
middle ear pressure [8,9,10]. Malfunction or malformation of the
bones and/or muscles around the eustachian tube can cause
obstruction or a patulous condition, which may result in excessive
middle ear fluid accumulation or retrograde infection through the
eustachian tube [11,12,13]. All evidence indicates a crucial role for
the eustachian tube in OM pathogenesis.
Craniofacial development influences eustachian tube function.
Craniofacial dysmorphology may change the position or angle of
the eustachian tube, and/or the location of surrounding muscles
that control the eustachian tube. These changes can cause
eustachian tube obstruction or incorrect opening and, ultimately,
OM [14,15,16,17,18,19]. Cleft palate malformation has been
clearly associated with OM [20,21]. Patients affected by
craniofacial dysmorphology, but not by a cleft palate, show
increased incidence of OM [15,22]. Thus, although these
conditions frequently occur together, one is sufficient for
predisposition to OM.
The expression of mouse protein SH3PXD2B (SH3 and PX
domains 2B, MGI: 2442062; synonymous with human TKS4) has
recently been correlated with formation of podosomes and
invadopodia, which mediate interactions between cells (normal
and cancerous, respectively) and the extracellular matrix [23]. The
SH3PXD2B protein is a member of the src tyrosine kinase substrate
family. SH3PXD2B can recruit the membrane type-1 matrix
metalloproteinase (MT1-MMP), resulting in extracellular matrix
degeneration [23,24]. Extracellular matrix remodeling is a
significant part of normal postnatal development of several tissues
and also in cancer cell invasion and migration [25,26,27]. The
Sh3pxd2b
nee mutation spontaneously arose in the mouse strain
B10.A-H2
h4/(4R)SgDVEg that was bred in the Jackson Laboratory
(Bar Harbor, ME, USA). This mutant bears a single base-pair
deletion in the last exon of the Sh3pxd2b gene on chromosome 11,
resulting in a frameshift mutation and premature stop codon, thus
eliminating the third and fourth SH3 domains of the SH3PXD2B
protein [23,24,28]. Sh3pxd2b
nee causes a craniofacial dysmorphology
phenotype featuring a domed skull, shortened maxilla, shortened
nose, glaucoma, growth retardation, adipose defects, and hearing
impairment, all reported previously [24,28]. These craniofacial
defects can lead to OM, among other defects. Humans with Frank-
ter Haar syndrome have a Sh3pxd2b gene defect that results in
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abnormalities, closely resembling the mouse phenotype [28].
Here, we show that the Sh3pxd2b
nee mutation leads to progressive
OM in mice through defects in craniofacial structure. Sh3pxd2b
nee
mutant mice exhibited a specific craniofacial dysmorphology and
eustachian tube alteration and all mutants developed OM with
onset as early as 11 days after birth. Mutant mice showed
progressive hearing impairment, tympanic membrane retraction,
and upregulated TNF-a and TLR2 in the middle ear. This
evidence demonstrates the similarities in development and
progression of OM between mice and humans affected by
craniofacial dysmorphology.
Materials and Methods
Mouse husbandry and genotype
Sh3pxd2d
nee heterozygous mice were obtained from the Jackson
Laboratory (Bar Harbor, ME) and bred at the Wolstein Animal
Research Facility at Case Western Reserve University. Because of
previously reported infertility in homozygous mutants [24], the
strain was maintained by heterozygous cross-mating. 52 homozy-
gous Sh3pxd2b
nee mutant mice and 66 wild-type littermate mice,
from 6 days to 3 months of age, were used. All mice were
genotyped by PCR and RsaI restriction enzyme (New England
Biolabs) digestion methods as reported previously [24]. Experi-
mental procedures were reviewed and approved by the Health
Sciences IACUC of Case Western Reserve University. (Protocol
numbers: 2008-0174 and 2008-0156).
Gross craniofacial phenotype and macroscopic ear
observations
Lateral view photos of 2.5-month-old Sh3pxd2b
nee mutant mice
(n=4) and wild-type littermate control mice (n=4) were taken by
digital camera (Canon 450D, Japan). Observation and comparison
of the features of this mutant were made directly from the photos.
Male Sh3pxd2b
nee mutant mice and male wild-type littermate
control mice were sacrificed by CO2 asphyxiation at a given time
point after birth (day 6, day 11, day 14, day 16, day 21, n=4 each
phenotype at each time point); then mice were skinned and
observed under a macroscope (Leica S6D, Germany). Ear and
tympanic membrane photos were taken for comparison.
Histological preparation of middle and inner ears
Bullae (including both middle and inner ear) were isolated from
ears of control (n=4 mice) and Sh3pxd2b
nee (n=3) mice at various
time points (ages 6, 11, 16 and 21 days, and 2.5 months; 4 mice
per age-group) for gross and histological pathology examination.
After dissection, bullae were fixed in 4% PFA for 24 hours and
then decalcified in 10% EDTA. For 11- to 21-day-old mice,
samples were decalcified for 7 days before embedding in paraffin
for sectioning. For 6- to 15-month-old mice, decalcification was for
21 days. Then samples were serially sectioned at 7 mm thickness
and mounted onto slides.
Hematoxylin and eosin staining; Mayer’s mucicarmine
staining
For hematoxylin and eosin (H&E) staining, a standard protocol
from Rosen’s lab was used (http://www.bcm.edu/rosenlab).
Mayer’s mucicarmine staining was used to identify goblet cells in
the middle ear mucosa following the manufacturer’s protocol
(Electron Microscopy Sciences). Sections were examined under a
light microscope (Leica DFC500, Germany). Images were
acquired at 5 to 636final magnification.
Scanning electronic microscopy
Bullae were isolated from skulls of 21-day-old control and
Sh3pxd2b
nee mice (n=4 mice, each genotype). Samples were placed
in 2.5% gluteraldehyde in cacodylic acid in 0.1 M phosphate
buffer (pH=7.2) for 36 hours. After decalcification in 10% EDTA
for 7 days, middle ear cavities were dissected from the bullae and
then dehydrated in serial solutions of ethanol (60%, 70%, 80%,
95%, 100%) for 15 minutes each, with a second soak in 100%
ethanol. Each middle ear cavity was subjected to carbon dioxide
critical point drying, sputter-coated with 60/40 gold-palladium,
and then viewed under a high-resolution scanning electron
microscope (Hitachi S-4500, Japan).
Scoring system for pathology of middle and inner ears
A scoring system of 2/+/++/+++ was used to assess the severity
of pathology in middle and inner ears. Symbols were assigned as
follows: 2, absence of pathology; +, very scarce pathology in the
middle or inner ear; ++, pathology prevalent, but not spanning the
entire middle or inner ear; +++, pathology spanning the entire
middle or inner ear. The scored pathologies included middle ear
effusion, inflammatory cell infiltration, tissue proliferation, goblet
cell density, and inner ear effusion. A chi-square test was used to
evaluate the semi-quantitative data. This method has been
reported in otitis media studies [29,30].
Skull preparation and craniofacial measurement
To measure craniofacial dimensions, skulls were dissected and
removed from mutant (n=8) and control (n=9) mice at age 3
months. The skulls were macerated in 1% KOH overnight to
remove soft tissue and then stained with alizarin red, as previously
described by M.C. Green [31]. To measure skull dimensions, a
hand-held digital caliper (General Tools & Instruments) of
0.01 mm resolution was used. This method was previously
validated for accuracy and precision [24,32]. 44 landmarks were
adapted from Dr. Joan Richtsmeier’s publication [32], and from
the standard measurement protocol in the craniofacial mutant
source (Jackson Laboratory, http://craniofacial.jax.org/standard
_protocols.html). The angle between the midline of the skull base
and the bony part of the eustachian tube was measured for
mutants and controls. Skulls were examined under an anatomical
microscope and the skull base was photographed. Screen ruler
software MB-Ruler 4.0 (Markus Bader, http://www.markus-
bader.de/MB-Ruler/download.htm) was used to precisely locate
the lines for angle measurement and to perform measurements.
Measurement data were analyzed using the Student t test.
Time-course ABR thresholds
Auditory-evoked brain stem response (ABR) was used to evaluate
hearing in Sh3pxd2b
nee mutant mice. The method has been reported
previously [33]. Mice were anesthetized with avertin (0.5 mg/g
body mass). A computer-aided evoked potential system (Intelligent
Hearing Systems) was used to record ABR thresholds for Sh3pxd2b
nee
mutant and control mice from 1 to 6 months of age. Student t test
was used to analyze the mean ABR thresholds at each time point.
Semi-quantitative RT-PCR
RNA was isolated from the bullae of four mutant and four
control 21-day-old mice using a pure-Link TM Micro-to-Midi
Total RNA Purification System (Invitrogen). The SuperScript III
First-Strand Synthesis System for RT-PCR was used to synthesize
cDNA. Relative mRNA expression levels for Tnf-a and Tlr2 were
determined by by PCR using Gapdh as the positive control. The
primers for these genes were previously described [30,34].
Mouse Craniofacial Dysmorphology and OM
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reverse: GGAGACAACCTGGTCCTCAG, yield a 351 bp prod-
uct. For Tnf-a, forward: CCACCACGCTCTTCTGTCTAC,
reverse: CCTTGAAGAGAACCTGGGAGT, yield a 303 bp
product. For Tlr2, forward: GAGCGAGCTGGGTAAAGTA-
GAAA, reverse: AGCCGAGGCAAGAACAAAGA, yield a
528 bp product. PCR was performed using Taq DNA polymerase
(New England Biolabs) with the following amplification conditions:
denaturation at 94uC for 2 min; followed by 31 cycles of 94uC for
30 sec, 56uC for 40 sec, 72uC for 50 sec; then extension at 72uC for
5 min. PCR products were subjected to 1.5% agarose gel
electrophoresis. To evaluate relative gene transcription levels, a
semi-quantitative method was used: Image J software (NIH) was
used to collect the gray intensity values of the Tnf-a and Tlr2 PCR
bands, which were corrected by the coefficient of Gapdh gene
expression of the same sample. Student t test was used to analyze
differences between relative gray intensity of PCR bands. The
method has been reported previously [30].
Immunostaining for TNF-a and TLR2
Middle ear paraffin sections were deparaffinized by immersion
in xylene twice, 5 min each; rehydrated in sequential aliquots of
100%, 95%, 80%, and 70% ethanol, 5 min each; and finally,
washed in water, 3 min. Then sections were covered with a trypsin
working solution (containing 0.1% calcium chloride [pH 7.8]) and
incubated 20 min at 37uC in a humidified incubator. Sections
were cooled and washed twice with PBS, 5 min each. Then 0.2%
Triton X-100 was added to sections for 5 min, followed by 2 more
washes in PBS, 5 min each. Next, blocking solution (3% goat
serum and 2% BSA) was applied for 1 hour followed by primary
antibodies anti-TNF-a (1:200 dilution) (Abcam, catalog #ab9739)
and anti-TLR2 (1:400 dilution)(Abcam, catalog #ab24192)
incubated overnight at 4uC. The next day, sections were washed
twice, 5 min each, in PBS; secondary antibody conjugated to
Alexa Fluor 488 (1:500 dilution; Invitrogen) was applied at room
temperature for 1 hr. Sections were washed twice with PBS;
propidium iodide (10 mg/ml, Invitrogen, catalog #P1304MP) was
applied at room temperature for 15 min to counterstain the nuclei.
Then sections were mounted in VECTASHIELDH Mounting
Medium (Vector Laboratories, Inc.) and observed under an
immunofluorescence microscope (Leica DFC500). Images were
acquired at 5 to 636final magnification.
Results
Gross examination of craniofacial structures and ears
At 2.5 months of age, homozygous mutant mice exhibited
obvious craniofacial dysmorphology (n=4, each phenotype,
Figure 1A) compared to wild-type controls. By anatomical
microscopy (Leica S6D), OM was detected in mice as young as
11 days old (Figure 1B). The mutant mice showed severe middle
ear effusion, sometimes accompanied by tympanic membrane
retraction (Figure 1D) resembling human OM pathology [35,36].
OM was detected in all mutant mice over 11 days of age, in
contrast to the wild-type control mice.
Histological observation of middle ears
Middle ear pathology was assessed at various stages to track
OM progression. In 6-day-old mice, middle ear cavitation had
already begun both in the Sh3pxd2b
nee mutant mice and wild-type
littermate control mice. Cavitation of the middle ear was larger
and appeared to proceed earlier in control mice than in mutants
(Figure 2A–D), but by 11 days, relatively normal development
was accompanied by effusion in the middle ear cavities of mutant
mice only. Furthermore, these middle ears also showed inflam-
matory cell infiltration and thickened epithelia (Figure 2E–H). In
16-day-old mice, epithelial thickening continued and inflammato-
ry cell numbers increased in the middle ears of mutant mice
(Figure 2I–L); the trend continued in 21-day-old mutant mice. At
21 days, inflammatory cells had spread throughout the middle ear
cavities of mutant mice as OM progressed and became more
severe with age. Control mice at 21 days still showed no OM
pathology (Figure 2O,P). At 2.5 months in mutant mice, the
previous middle ear pathology was accompanied by fibroblastic
proliferation and capillary hyperplasia (Figure 3A,B), a higher
density of goblet cells in the middle ear mucosa revealed by
Mayer’s mucicarmine staining (Figure 3C,D), and a thickened
tympanic membrane (Figure 3E,F), all in contrast to control
mice. Histological sections revealed that the eustachian tube in
mutant mice was heavily infiltrated by inflammatory cells
(Figure 3G,H). Individual mutant mice showed differing degrees
of middle ear inflammation, at various ages, with excessive effusion
and inflammatory cells, most of which were neutrophilic
granulocytes, along with a few macrophages (Figure 3I,J). Thus,
the mucus-secreting ability of the middle ear epithelium was
enhanced in the mutant mice, and the excretion ability of the
eustachian tube was diminished, leading to excessive effusion in
OM. To measure the degree of pathology in OM, five indices were
Figure 1. Gross phenotype in Sh3pxd2b
nee mutant mice. A,
Comparison of the lateral view of a 20-day-old male mutant mouse (left)
and a wild-type littermate control mouse (right). The mutant mouse
exhibits a domed and rounded skull, and a shortened nose. B,C,
Macroscopic views of the tympanic membranes of an 11-day-old male
mutant mouse (B) and a wild-type littermate male control mouse (C).
The surface of the tympanic membrane is covered by thick, white
exudate (arrow) in the mutant mouse ear, making the tympanic
membrane adiaphanous and uneven (B). In the ear of the control
mouse, the ossicles are clearly visible through the smooth, transparent
tympanic membrane (C). D,E, Macroscopic views of the tympanic
membranes of a 14-day-old male mutant mouse (D) and a wild-type
littermate control mouse (E). The mutant mouse exhibits a relatively
more protuberant malleus, which indicates that there is tympanic
membrane retraction (D, arrow). The control mouse has a relatively
even malleus and tympanic membrane, when compared to the mutant
mouse (E). (M=mutant, WT=wild-type, m=malleus, tm=tympanic
membrane). Scale bar, 200 mm.
doi:10.1371/journal.pone.0022622.g001
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data revealed that all of the tested Sh3pxd2b
nee mutant mice had
signs of inflammation in their ears and that the degree of
inflammation in ears of Sh3pxd2b
nee mutant mice was significantly
greater than that in ears of wild-type control mice.
Scanning electronic microscopy observation
We assessed changes in cilia and goblet cells of the middle ear
mucosa from 21-day-old Sh3pxd2b
nee mutant mice using scanning
electronic microscopy. Wild-type littermate control mice displayed
a thick lawn of morphologically normal, evenly distributed cilia in
the mucociliary epithelia of the middle ears. In comparison, the cilia
were diminished and sparsely distributed in the mucociliary
epitheliaofmiddleearsfrom Sh3pxd2b
neemutantmice.Furthermore,
an elevated density of goblet cells was evident in the mutant middle
ear mucosa. A high density of goblet cells was not found in the
middle mucosa from the wild-type control mice. (Figure 4A–B).
Craniofacial measurement
Craniofacial measurements showed that the mutant mice had a
statistically significant (p,0.01) decreased linear distance between
craniofacial landmarks for all but four measurements taken. The
Figure 2. H&E histology shows development of middle ear structures and pathology. Each group of four panels consists of representative
images of the middle ears at a single time point after birth: day 6 (A–D), day 11 (E–H), day 16 (I–L), and day 21 (M–P). For each time point, the top
two panels show images from a Sh3pxd2b
nee mutant (M) mouse (56magnification, left panel; 206magnification of boxed region of interest, right
panel) and the lower two panels show corresponding images from a wild-type (WT) littermate control mouse. In 6-day-old mice (n=4, each
genotype), the middle ear cavity (ME) is filled with mesenchymal cells (asterisks, A–D), and middle ear cavitation has already begun. Cavitation of the
middle ear is larger and proceeds earlier in control mice than in mutants (arrows, A–D). At 11 days of age (n=4, each genotype), the mesenchymal
cells have disappeared and middle ear cavitation is almost complete in both the mutant (E) and control (G) mice. Signs of infiltration by inflammatory
cells are beginning to show in the middle ears of the mutant mice (E, arrows). The middle ear epithelium has also become thickened in the mutant
mice (F, two-ended arrow). At age 16 days (n=4, each genotype), more inflammatory cells can be found in the middle ear cavity (I, arrow), and the
epithelium has thickened even more, as compared to the mice at age 11 days (J, two-ended arrow). At age 21 days (n=4 each genotype),
inflammatory cells have significantly increased and are observed throughout the middle ears of the mutant mice (M, arrow). The middle ear
epithelium has also greatly thickened in the mutant mice (N, two-ended arrow).
doi:10.1371/journal.pone.0022622.g002
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The average skull length (Figure 5A, landmark 1-landmark 20) of
control mice was 22.00 mm; whereas, the average skull length of
mutant mice was 16.08 mm. The average skull width (Figures 5A,
landmark 19-landmark 21) of controls was 10.44 mm versus
8.91 mm for mutants. The average skull height (Figure 5E,
landmark 14-landmark 44) for controls was 10.34 mm, versus
8.35 mm in mutants. The average lower jaw length (Figure 5E,
landmark 40-landmark 38(39)) in controls was 11.71 mm, versus
8.63 mm in mutants. The average upper jaw length (Figure 5E,
landmark 1-landmark 13(15)) in controls was 14.39 mm compared
to 9.93 mm in mutants. The average nose length (Figure 5A,
landmark 1-landmark 7) in controls was 10.28 mm, compared to
8.43 mm in mutants. The average interorbital distance
(Figure 5A, landmark 6-landmark 8) in controls was 5.60 mm,
compared to 5.29 mm in mutant mice. (Measurement data are not
shown). All of these measurements showed statistically significant
differences in the mean distances between mutant and con-
trol mice (p,0.01) except for the interorbital distances
(p.0.05)(Figure 6A). Between the midline of the skull base and
the bony part of the left and right eustachian tubes (angles 1 and 2
in Figure 6B,C), mutant mice had significantly larger angles in
angle 1: 59.6u versus 40.3u for controls, and in angle 2: 59.64u
versus 40.00u for controls (measurement data not shown)
(Figure 6C, angle 1 and 2; P,0.01). Thus, there were clearly
alterations that would produce a more horizontal orientation of
the eustachian tubes in Sh3pxd2b
nee mutant mice, paralleling the
eustachian tube morphology in humans that may cause a
predisposition for OM.
Time-course ABR thresholds
ABR thresholds were measured in Sh3pxd2b
nee mice and controls
several times between one and six months of age and showed a
consistent increase in mutant mice (Figure 7). ABR threshold
mean values above 55 (for click stimuli), 40 (for 8 kHz), 35 (for
16 kHz) and 60 (for 32 kHz) decibel sound pressure levels (dB
SPL) indicate hearing impairment [37]. There was a tendency
toward elevation at higher stimulus frequencies both in mutant
and control mice (Figure 7C,D; 16 kHz and 32 kHz). At each
time point, the gap between ABR threshold mean values of mutant
and control mice tended to decline as stimulus frequency was
elevated (Figure 7B,C; 8 kHz and 16 kHz). Then we compared
Figure 3. Signs of inflammation and otitis media in Sh3pxd2b
nee mutant mice (M) compared with controls (WT). A,B, Representative
images comparing pathological changes in the middle ears between Sh3pxd2b
nee mutant mice (A) and wild-type littermate control mice (B)a t
the age of 2.5 months. The Sh3pxd2b
nee mutant mice show thickened middle ear mucosae (A, two-ended arrow). The middle ear cavity of mutant
mice is filled with fibroblastic tissue, showing fibroblastic proliferation (A, thin arrows) and capillary hyperplasia (A, bold arrow). The wild-type
control mice show a thin mucosa (B, arrow) and a clear middle ear cavity without fibroblastic proliferation or capillary hyperplasia. C,D,
Representative images to show goblet cells in the middle ear epithelium in the mutant mice (C) and wild-type littermate control mice (D)a tt h e
age of 21 days. There was a relatively higher density of goblet cells in the middle ear epithelium in the mutant mice as compared to the littermate
controls (C,D arrows). E,F, Representative images comparing tympanic membrane thickness in Sh3pxd2b
nee mutant mice (E)a n dw i l d - t y p e
littermate control mice (F) at the age of 2.5 months. The tympanic membrane has become significantly thickened in the mutant mice (E, arrow);
whereas, the control mice show a thin tympanic membrane (F, arrow). G,H, Representative images of the eustachian tube in mutant mice (G)a n d
littermate control mice (H) at age 21 days. The eustachian tube is filled with inflammatory cells in mutant mice (G, arrow), compared with normal
clearance of the eustachian tube in control mice (H). I,J, Infiltrated cells are evident in the middle ear cavity of a 21-day-old mutant mouse. J is an
enlarged view of the boxed region of interest in panel I. Infiltrated cells exhibit a polymorphic nucleus (J, small arrows). A few macrophages
can also be found (J, bold arrows). Scale bar(s), panel I,1 0 0mm; panels G,H, 50 mm; all other panels, 10 mm. Panel I, 56 magnification; other
panels, 636magnification. Panels C,D, Mayer’s mucicarmine stain; all other panels, H&E stain. ME=middle ear cavity, M=mutant, WT=wild-type
control.
doi:10.1371/journal.pone.0022622.g003
Mouse Craniofacial Dysmorphology and OM
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mutant hearing levels minus mean hearing level of wild-type),
which represent the degree of hearing impairment, between the
lower stimulus frequencies (8 kHz Figure 7B) and higher stimulus
frequencies (32 kHz, Figure 7D). We found statistically signifi-
cant differences at each time point (Student t test, P,0.005, 1
through 6 months). These results demonstrated that the mutation
affects hearing at lower stimulus frequencies more than at higher
stimulus frequencies.
Increased mRNA and protein expression for Tnf-a and
Tlr2
Gapdh-correlated, semi-quantitative RT-PCR analysis revealed
that mRNA expression levels in the middle ear in four 24-day-old
Sh3pxd2b
nee mutant mice were increased for the pro-inflammatory
cytokine Tnf-a and for cell surface receptor Tlr2 which aids in
pathogen recognition (Figure 8,*P ,0.05, **P,0.01, respectively).
To determine whether protein levels of TNF-a and TLR2 were
upregulated in Sh3pxd2b
nee mice, we analyzed the expression of
each in situ. Paraffin sections of middle ears from control and
Sh3pxd2b
nee mutant 21-day-old mice were stained with anti-TNF-a




Effusion Inflammatory Cells Tissue Proliferation Goblet Cells
Inner Ear Neutrophil
Infiltration
1 WT 22 2 2 2
2 WT + 22 2
3 WT 22 2 2 2
4 WT 22 2 2 2
5 WT 22 2 2 2
6 WT 22 2 2 2
7 WT 22 2 2 2
8 WT 22 + 22
9 WT + 22 + 2
10 WT 22 2 2 2
11 WT 22 2 2 2
12 WT 22 2 2 2
13 Sh3pxd2b
nee ++ + + 2
14 Sh3pxd2b
nee ++ ++ + + 2
15 Sh3pxd2b
nee + 2 + 2 +
16 Sh3pxd2b
nee + ++ +++ ++ 2
17 Sh3pxd2b
nee ++ ++ + 22
18 Sh3pxd2b
nee ++ +++ + + 2
19 Sh3pxd2b
nee ++ ++ ++ + 2
20 Sh3pxd2b
nee ++ ++ ++ ++ 2
21 Sh3pxd2b
nee ++ + + 2
22 Sh3pxd2b
nee ++ + 2 + 2
23 Sh3pxd2b
nee ++ + + + + +
24 Sh3pxd2b
nee +++ +++ + +++ 2
25 Sh3pxd2b
nee ++ + + 2
To show the degree of pathological alteration in the middle ears of control and mutant mice, symbols (2, +, ++,a n d+++) were used with (2) indicating no pathology
and (+)t o( +++) indicating little to great degree of pathology, respectively. Criteria for pathology included middle ear effusion, density of inflammatory cells, degree of
tissue proliferation, density of goblet cells, and degree of inner ear effusion. Both ears were examined, and the recorded finding pertains to the ear with the greatest
degree of pathology. We scored 1 point for each +; for a total maximum possible score of 15 points per mouse. The total scored rate (77/195) of 13 Sh3pxd2b
nee mutant
mice was significantly higher than that (4/180) of 12 wild-type mice (p,0.01, Chi-square test). Mice from 60–90 days of age were used.
doi:10.1371/journal.pone.0022622.t001
Figure 4. Scanning electron microscopic view of the middle ear
mucosa. A, Representative image from a 21-day-old wild-type
littermate control mouse. Arrows indicate cilia in the mucociliary
epithelium of the middle ear with a visually normal morphology. B
Representative image from a 21-day-old Sh3pxd2b
nee mutant mouse.
Arrows indicate the sparsely distributed cilia in the mucociliary
epithelium of the middle ear. Cilia also showed abnormal morphology
compared with those in the wild-type control. Asterisks indicate the
increased numbers of goblet cells in the swollen middle ear mucosa;
whereas, only a few goblet cells (A, asterisk) could be found in the
middle ear mucosa of wild-type control mice. WT=wild-type, M=
mutant, Scale bars=5 mm.
doi:10.1371/journal.pone.0022622.g004
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22622Figure 5. Landmarks and linear distances used in craniofacial measurement*. A, Vertical views of skull: 1 Apex point of nose bone; 2,3
Anterior-most point at intersection of premaxilla and nasal bones; 4,5 anterior notch on frontal process lateral to infraorbital fissure; 6,8 intersection of
frontal process of maxilla with frontal and lacrimal bones; 7 nasion point; 9,12 intersection of zygomatic process of maxilla with zygoma; 10,11 frontal-
squasmosal intersection at temporal crest; 13,15 intersection of zygoma with zygomatic process of temporal; 14 bregma; 16,18 joining of squasmosal
body to zygomatic process of squasmosal; 17 intersection of parietal and interparietal bones; 19,21 intersection of parietal, temporal and occipital
bones; 20 intersection of interparietal and occipital bones at the midline. (B) Lateral view of skull: 22 center of alveolar ridge over maxillary incisor. 23
most inferior point on the premaxilla-maxilla suture; 24 intersection of maxilla and sphenoid on interior alveolar ridge. Other landmarks are identical
with the landmarks in panel (A). The symmetric overlapping landmarks are in brackets. (C) Vertical view of mandible: 26,27 superior-most point on
incisor alveolar rim; 28,29 anterior point on molar alveolar rim; 30,31 intersection of molar alveolar rim and base of coronoid process; 32,33 coronoid
process; 34,35 anterior-most point on mandibular condyle; 36,37 posterior-most point on mandibular condyle; 38,39 mandibular angle. (D) Lateral
view of mandible: 40 inferior-most point on incisor alveolar rim; 41 mental foramen; 42 inferior-most point on border of ramus inferior to incisor
alveloar. 43 superior-most point on inferior border of mandibular ramus. Other landmarks are identical with the landmarks in panel (C), The
symmetric overlapping landmarks are in brackets. (E) Craniofacial lateral view: 44 the inferior-most point on border of mandibular ramus. Other
landmarks are identical with the landmarks in panels (A–D), the symmetric overlapping landmarks are in brackets. Straight lines were drawn between
the landmarks in panels (A–E). In the mutant mice, the linear distance between each landmark pair is significantly shorter than those in the wild-type
control mice (Student t test, p,0.05), except for the 4 distances: landmark 6-landmark 8, landmark 6-landmark 7, landmark 7-landmark 8, and
landmark 10-landmark 11 (Student t test, p.0.05). Seven linear distances were selected to evaluate the craniofacial morphology: skull length (Panel
A, landmark 1-landmark 20), skull width (Panel A, landmark 19-landmark 21), skull height (Panel E, landmark 14-landmark 44), lower jaw length (Panel
E, landmark 40-landmark 38(39)), upper jaw length (Panel E, landmark 1-landmark 13(15)), nose length (Panel A, landmark 1-landmark 7) and
interorbital distance (Panel A, landmark 6-landmark 8) separately. * Landmarks are mostly following Dr. Joan Richtsmeier’s paper on craniofacial
dysmorphology in a Down syndrome mouse model [32], and the standard measurement protocol in the Jackson Laboratory Craniofacial mutant
source (Jackson Laboratory, Bar Harbor, ME http://craniofacial.jax.org/standard_protocols.html).
doi:10.1371/journal.pone.0022622.g005
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cavity, TNF-a was upregulated in mutant mice compared to wild-
type controls (Figure 9A–F). TLR2 immunostaining showed a
very similar pattern to that seen for TNF-a (Figure 9G–L). In
both cases, antibodies specific for TNF-a or TLR2 stained the
middle ear mucosa of mutant mice much more brightly than the
control samples and this staining was localized to the cytoplasm of
epithelial cells and of inflammatory cells. The protein levels seen
by immunohistochemistry correlated with the up-regulation of
mRNA observed by RT-PCR.
Discussion
In our study, we explored the hypothesis that gene mutation
leading to craniofacial dysmorphology increases susceptibility to
OM with effusion and we validated the Sh3pxd2b
nee mutant mouse
as an animal model for this. Craniofacial dysmorphology is
heritable through gene mutation [37], but how mutations in genes
linked to craniofacial development lead to pathologies such as OM
is unclear [37,38]. Using the Sh3pxd2b
nee mouse model, we
examined the role of Sh3pxd2b mutation in craniofacial dysmor-
phology and development of OM. Previous studies confirmed that
mutation in Sh3pxd2b leads to craniofacial dysmorphology and
OM [24]; our study examined OM progression and included
hearing assessment throughout development. Together with
measurement of middle ear inflammatory factor expression, our
study more fully characterizes the OM and associated pathologies
resulting from Sh3pxd2b mutation.
We compared craniofacial structural dimensions of control and
mutant mice, analyzed middle and inner ear pathologies, and
tested hearing thresholds through various developmental stages.
We measured mRNA and protein expression of TNF-a and
TLR2, previously reported in OM research [30,34,39,40,41], to
determine whether these inflammatory factors were upregulated in
Figure 6. Assessment of craniofacial dysmorphology in Sh3pxd2b
nee mice. A, Comparison of linear distance parameters of the craniofacial
dimensions of 2.5-month-old Sh3pxd2b
nee (mutant, n=8, purple bars) and wild-type (control, n=9, blue bars) mice. All but one measurement
parameter yielded statistically significant differences between mutant and control mice (Student t test, * P,0.01). The interorbital distance showed
no significant difference (Student t test, P.0.05). Error bars indicate the standard deviation from the mean for each group. B,C, Comparison of
eustachian tube angles 1 and 2, from the mid-line of the skull to the left and right ears, respectively. Panel (B) shows an antiapical view of a
dissected skull with the lines of reference for the measured angles indicated. ML, mid-line; Eu, eustachian tube. Panel (C) shows a graphic
comparison of the mean values for angles 1 and 2 between mutant (n=8) and wild-type control (n=9) mice. The mutant mice had statistically
significant larger angles than the wild-type control mice (Student t test, *P,0.01). Error bars indicate the standard deviation from the mean of each
group.
doi:10.1371/journal.pone.0022622.g006
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findings showed that all Sh3pxd2b
nee mice were born with
craniofacial dysmorphologies and developed OM, as early as 11
days of age, with associated pathologies progressively worsening.
Furthermore, the mutant mice showed impaired hearing that was
statistically more pronounced at lower frequencies. The type of
hearing impairment caused by otitis media is conductive hearing
loss when active otitis media exists. It is difficult to perform bone-
conduction ABR in the mice because the mouse head is so small.
In human patients with active otitis media, lower frequencies are
more compromised than higher ones [42]. The mutant mice
showed increased mRNA and protein levels of TNF-a and TLR2,
which are consistent with the activation of inflammation pathways
shared with other OM in mice and humans [29,37,43].
Agreeing with a previous study [24], our findings confirmed
craniofacial dysmorphology in Sh3pxd2b
nee mutant mice and, for
the first time in this model, showed eustachian tube dysmorphol-
ogy, which has been closely linked to OM development in children
[1,2]. Specifically, craniofacial dysmorphology led to a positional
change of the eustachian tube. The angle between the midline of
the skull base and the bony part of the eustachian tube was
increased in mutant mice, on both the right and left sides, thus
imparting a more horizontal orientation to the bony part of the
eustachian tube. Other signs of pathology in the mutant mouse
eustachian tube included thickened epithelium, presence of
inflammatory cells, and a narrowed tympanic cavity opening of
the eustachian tube. This is the first demonstration in mouse of
these alterations of the eustachian tube which are associated with
craniofacial dysmorphology and are all phenotypic outcomes that
accompany OM.
Time-course examination of OM pathology progression
revealed 11-day-old mutant mice with a much higher degree of
middle ear effusion (a primary sign of OM) than control mice. By
2.5 months, mutant mice also showed fibroblast proliferation, and
increased goblet cells and inflammatory cells. These phenotypic
outcomes are consistent with findings in human patients [44,45].
Older mice also exhibited more tissue repair reaction in the middle
ears.
Cilia present on the mucociliary epithelia of the healthy middle
ear are critical for the clearance of secretions. Goblet cells
associated in normal numbers with the mucociliary epithelia of the
middle ear mucosa are involved in the production of mucosal
secretions and contribute to a normal immune response
[38,46,47]. Our findings reveal morphological abnormalities of
Figure 7. Impaired hearing in Sh3pxd2b
nee mice. A time-course observation of ABR thresholds of right ears from mutant (n=30) and littermate
control (n=30) mice, tested at the ages of 1, 2, 3, 5, and 6 months. Compared to littermate controls, the mutant mice exhibit significantly higher
mean ABR threshold values at every age point and at every stimulus frequency (click stimuli, 8 kHz, 16 kHz, 32 kHz in panels A, B, C, D,
respectively)(Student t test, p,0.01). There appears to be a tendency toward increased hearing threshold at higher stimulus frequencies, both in
mutant and control mice. In addition, the higher the frequency, the closer the curves for the mutant and control mice were. This indicates that at the
same age point, the gap between the mean ABR thresholds between the mutant and control mice had a declining tendency as the stimulus
frequencies increased. Thus, the observed pathology has a greater effect on hearing ability at lower frequencies than at higher frequencies. Error bars
represent standard error of the mean.
doi:10.1371/journal.pone.0022622.g007
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inability to clear secretions in Sh3pxd2b
nee mutant mice. We also
found a high density of goblet cells in the middle ear mucosa of
mutant mice, which may further explain the accumulation of
excessive exudate in the middle ear cavities of these mice.
Mutant mice demonstrated impaired hearing upon auditory
brainstem response testing, which determines the minimum
threshold of hearing at different sound frequencies. We examined
hearing at ages 1, 2, 3, 5 and 6 months and found significantly
impaired hearing as early as 1 month. A tendency toward
increased hearing threshold with age was evident at higher
frequencies. Overall, however, hearing impairment of mutant
mice was more pronounced at lower frequencies. Thus, the
pathological hearing effects associated with this mutation are
complex because hearing is affected differently depending on
sound frequency and mouse age.
When craniofacial dysmorphology is present, secretions cannot
be cleared from the middle ear cavity through the eustachian
tube, and bacteria can accumulate, leading to inflammation [38].
Failure to clear secretions because of eustachian tube dysfunction
can probably explain the upregulation of inflammatory factors in
Sh3pxd2b
nee mice. Toll-like receptors (TLRs) function on host cell
surfaces to recognize pathogens and recruit cytokines and other
immune effectors. Other studies have shown that TLR2 was
present in the middle ears of patients with OM [34,39,40,41].
Our findings show that TLR2 was upregulated in the mutant
mice.
Conclusion
Our study shows that a mutation in the Sh3pxd2b gene, which
affects craniofacial development in mutant mice, led to OM that
mimics the human disease in a number of important physiologic
and metabolic parameters. This is the first mouse model to exhibit
eustachian tube morphology that mimics the eustachian tube
morphology in humans which has been linked to OM. Further
examination of genes such as the Sh3pxd2b gene are warranted to
further elucidate how these proteins are involved in onset and
progression of craniofacial dysmorphology and OM. Identifying
the relationships between Sh3pxd2b and other genes and between
SH3PXD2B protein and other proteins is an important step
toward understanding craniofacial development and the onset of
OM, ultimately promoting treatment and prevention options.
Figure 8. Evidence of active inflammation in ear tissue of Sh3pxd2b
nee mutants up-regulation of pro-inflammatory molecules. Gene
expression levels were detected in bullae from 21-day-old Sh3pxd2b
nee mutant mice (n=4) and wild-type littermate control mice (n=4). Panel A
shows in graphic form the semi-quantitative difference in Tnf-a (left panel) and Tlr-2 (right panel) mRNA expression between wild-type and mutant
mice as measured relative to Gapdh expression. The mRNA accumulation levels of Tnf-a and Tlr2 were significantly higher in Sh3pxd2b
nee mutant mice
than in wild-type littermate control mice (Student t test, * P,0.05, **P,0.01). Error bars indicate the standard deviations from the means in each
group. Panel (B) presents the semi-quantitative RT-PCR results summarized in A. After 1.5% gel electrophoresis, Image J software (NIH) was used to
collect the gray intensity values of each band on the gel. The mRNA accumulation level of each was corrected by the coefficient of Gapdh gene mRNA
accumulation level of the same sample.
doi:10.1371/journal.pone.0022622.g008
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nee mutant mice. Representative immunohistochemistry figures
show the staining of middle ear tissue with anti-TNF-a (A–F) and anti-TLR-2 (G–L) antibodies, revealed with Alexa-Fluor 488 (green). The top 3 panels
in each set (A,B,C and G,H,I) are from wild-type control mice, and the lower 3 panels (D,E,F and G,K,L) are from Sh3pxd2b
nee mutant mice, all at 21
days of age. Panels on the left (A,D and G,J) are low magnification images (scale bar=100 mm) revealing the gross morphology of the middle ears.
Middle panels (B,E and H,K) are enlarged images of the regions of interest boxed in the corresponding left panels. These images reveal the middle
ear mucosa and epithelium. Panels on the right (C,F and I,L) are merged from the middle panels (B,E and H,K) and images counterstained with
propidium iodide in red (not shown separately) to reveal the nuclei in these tissues. ME=middle ear cavity, IE=inner ear, arrows indicate the middle
ear mucosa in each panel. In the middle and right panels, scale bar=10 mm. The staining intensities for both TNF-a and TLR-2 are stronger in the
Sh3pxd2b
nee mutant mice than in the wild-type control mice (left panels) Upon higher magnification, it can be appreciated that the staining intensity
of both antibodies was much stronger in the middle ear mucosa (middle panels) and localized to the cytoplasm of middle ear epithelial cells (right
panels) of the Sh3pxd2b
nee mutant mice, compared with the weaker staining in wild-type control mice. The inflammatory cells in the middle ear
cavities of the Sh3pxd2b
nee mutant mice also show a strong cytoplasm staining intensity of both antibodies (E,F,K,L).
doi:10.1371/journal.pone.0022622.g009
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